Physician profile
Nikko Dunlevy
NPI 1669889705
$618.07
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $208 · 2021: $276 · 2022: $23.38.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $268.53 | 2019-2022 | |
| Therapeuticsmd, INC. | $119.03 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $65.83 | 2020-2021 | |
| Allergan, INC. | $42.58 | 2019-2020 | |
| Agile Therapeutics, INC. | $21.49 | 2021 | |
| Avion Pharmaceuticals | $18.31 | 2021 | |
| Vertical Pharmaceuticals, LLC | $18.30 | 2019 | |
| Evofem Biosciences, INC. | $15.95 | 2020 | |
| Covidien LP | $12.79 | 2019 | |
| Coloplast Corp | $12.62 | 2021 | |
| Medicem INC. | $11.52 | 2020 | |
| Aspira Women'S Health INC | $11.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikko Dunlevy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.